Related Experiment Video
Updated: Jun 15, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Deep Brain Stimulation in Leigh-Like Syndrome Due to DNM1 Pathogenic Variant
Leonel Villa-Villegas1, Luz Gabriela Lira-Jaime1, Katia Carmina Farías-Moreno1
1Movement disorders and neurodegenerative diseases unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, México.
Clinical Vignette:
Leigh syndrome (LS) and Leigh-like syndromes (LLS), now collectively referred to as Leigh Syndrome Spectrum (LSS), encompass a wide range of clinical manifestations, including epilepsy, neurodevelopmental delay, and movement disorders such as ataxia, chorea, and dystonia. Although rare, LSS can present atypical symptoms in certain cases. The primary etiological cause of LSS is genetic, resulting from mitochondrial alterations.
Clinical Dilemma:
Hyperkinesias in LSS or other mitochondrial disorders can be disabling, leading to a significant reduction in the patient's quality of life.
Clinical Solution:
Globus pallidum deep brain stimulation (GPi-DBS) surgery is an effective treatment for hyperkinesias, such as chorea, and dystonia, caused by mitochondrial defects.
Gap In Knowledge:
Pathogenic DNM1-related mitochondrial disorders with Leigh syndrome phenotype may show long-term improvement of hyperkinetic movements after GPi-DBS.
Related Concept Videos
Alzheimer Disease l: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy

